SOLICITATION NOTICE
66 -- Metagenomic Microarray Development - Notice of Intent
- Notice Date
- 8/30/2013
- Notice Type
- Presolicitation
- NAICS
- 334516
— Analytical Laboratory Instrument Manufacturing
- Contracting Office
- Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 3900 NCTR Road, HFT-320, Bldg 50 | Rm 421, Jefferson, Arkansas, 72079, United States
- ZIP Code
- 72079
- Solicitation Number
- FDA-13-1124695
- Archive Date
- 9/21/2013
- Point of Contact
- Christopher R. McGucken, Phone: 3018277161
- E-Mail Address
-
christopher.mcgucken@fda.hhs.gov
(christopher.mcgucken@fda.hhs.gov)
- Small Business Set-Aside
- N/A
- Description
- Notice of Intent The U.S. Food and Drug Administration (FDA) intends to negotiate a Firm Fixed Price sole source purchase order with TessArae,LLC. Located at 858 Horton Street, Suite 555 Emeryville, CA 94608 for the acquisition of microarrays sequenced as follows (Array, FDAGUTA520821F) and (Array, FDAECSGa520423F). The microarrays are unique products that are licensed exclusively by TessArae, LLC. Therefore, is the only responsible source to provide the necessary Service and replacement of parts to support FDA’s mission. In accordance with FAR 5.207(c)(16)(ii), vendors that feel they can meet the Government's requirements detailed above may submit a capability statement which shall be considered by the agency. A determination by the Government not to open the requirement to competition based on responses to this notice is solely within the discretion of the Government. In accordance with FAR 6.305(a) the justification will be made publicly available within 14 days after award has been made. The acquisition will be conducted through the Federal Acquisition Regulation (FAR) Part 13 "Simplified Acquisition Procedures". The North American Industry Classification System (NAICS) code for this requirement is.811219 The business size standard is $19 million. THIS NOTICE IS NOT A REQUEST FOR COMPETITIVE PROPOSALS, however, interested firms may submit a capability statement in response to the above requirement with cost/price information by September 6th, 2013 @ 12:00 PM EST to Christopher R. McGucken, Contract Specialist, Phone: (301) 827-7161, Email: Christopher.McGucken@fda.hhs.gov. A determination not to open competition based responses to this notice is solely within the discretion of the Government.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/NCTR/FDA-13-1124695/listing.html)
- Record
- SN03169720-W 20130901/130830234841-f391203e4160fc5ed16868722519b22e (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |